Innovative Eyewear Inc (LUCYW): Shareholders' Equity

Annual figures by period end, from SEC filings.

$9.07M
As of 2025-12-31
$6.90M
As of 2026-06-30
+31.1%
3-year compound annual growth
$9.10M2021-12-31: $207.5K2022-12-31: $4.02M2023-12-31: $5.56M2024-12-31: $9.10M2025-12-31: $9.07M$9.07M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$9.07M-0.3%2026-03-25, Balance as of period end
2024-12-31$9.10M+63.6%2026-03-25, Balance as of period end
2023-12-31$5.56M+38.1%2025-03-24, Balance as of period end
2022-12-31$4.02Mn/m2024-03-25, Balance as of period end
2021-12-31$207.5Kn/a2023-03-24, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Innovative Eyewear Inc (LUCYW)2025-12-31$9.07M-0.3%
RxSight, Inc. (RXST)2025-12-31$275.68M-2.0%
Staar Surgical Co (STAA)2026-01-02$344.18M-13.4%
Warby Parker Inc. (WRBY)2025-12-31$367.73M+8.1%
National Vision Holdings, Inc. (EYE)2026-01-03$869.53M+6.5%
Cooper Companies, Inc. (COO)2025-10-31$8.24B+1.9%
Bausch & Lomb Corp (BLCO)2025-12-31$6.52B-0.4%

Compare LUCYW, RXST, STAA, WRBY side by side · Screen every company in Ophthalmic Goods ↗